Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy

Pre-eclampsia and/or fetal death have increased sharply in HIV-infected pregnant women receiving HAART. The occurrence of pre-eclampsia or fetal death was analysed in women who delivered after at least 22 weeks of gestation for all women (January 2001 until July 2003) and for HIV-infected women (Nov...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2006-01, Vol.20 (1), p.59-66
Hauptverfasser:	SUY, Anna, MARTINEZ, Esteban, MALLOLAS, Josep, LEON, Agathe, VANRELL, Juan A, GATELL, José M, COLL, Oriol, LONCA, Montserrat, PALACIO, Montserrat, DE LAZZARI, Elisa, LARROUSSE, Maria, MILINKOVIC, Ana, HERNANDEZ, Sandra, BLANCO, José L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiretroviral Therapy, Highly Active - adverse effects Biological and medical sciences Diseases of mother, fetus and pregnancy E-Selectin - blood Female Fetal Death - chemically induced Fetal Death - etiology Gynecology. Andrology. Obstetrics HIV Infections - complications HIV Infections - drug therapy Human immunodeficiency virus Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Insulin - blood Medical sciences P-Selectin - blood Parity Pre-Eclampsia - chemically induced Pre-Eclampsia - etiology Pregnancy Pregnancy Complications, Infectious - drug therapy Pregnancy Outcome Pregnancy. Fetus. Placenta Prospective Studies Risk Factors Smoking - adverse effects Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!